J&J contact lenses recalled

accreditation

Health giant Johnson & Johnson has issued its ninth recall of a consumer health product in a year, this time covering millions of 1 Day Acuvue contact lenses sold in Japan and several other countries in Asia and in Europe.

Johnson & Johnson said it had received a limited number of complaints from customers in Japan that they experienced an unusual stinging or pain when inserting the Acuvue TruEye Brand contact lenses.

J&J, based in New Brunswick, New Jersey, said it has not received any reports of customers suffering damage to their vision.

"The risk of long-term health consequences is very unlikely," Gary Esterow, spokesman for Johnson & Johnson Vision Care Inc., told The Associated Press.

100,000 boxes affected

He said the company estimates about 100,000 boxes were affected, with the boxes containing either 30 or 90 lenses each. The lenses were manufactured in Ireland.

Esterow attributed the problem to a failure of a piece of equipment during a procedure when the lenses are rinsed. He said only one manufacturing line was involved, but could not say how many lines manufacture the contacts.

The affected contact lenses were not sold in the US or Canada, he said. Most were sold in Japan.

Johnson & Johnson has issued eight previous recalls of non-prescription medicines in the US since last September, including children's Tylenol and millions of bottles of other pain relievers and cold medicines for children and adults.

Johnson & Johnson under scrutiny

As a result, Johnson & Johnson has been under scrutiny by Congress, FDA officials and federal prosecutors. The series of recalls covered products made at J&J's Fort Washington, Pa., plant and another in Las Piedras, Puerto Rico.

They have involved problems ranging from contamination with bacteria and a nauseating smell on containers to liquid medicines that may contain tiny metal shavings, and drugs that may not have the correct amount of active ingredient.

J&J shares rose 34 cents to $59.08 (about R437) in afternoon trading, on a day when large US pharmaceutical companies were up somewhat. (Sapa, Linda A Johnson, August 2010)

Read more:

FDA probes tylenol recall

Lady Gaga eye lense fad is dangerous

We live in a world where facts and fiction get blurred
In times of uncertainty you need journalism you can trust. For 14 free days, you can have access to a world of in-depth analyses, investigative journalism, top opinions and a range of features. Journalism strengthens democracy. Invest in the future today. Thereafter you will be billed R75 per month. You can cancel anytime and if you cancel within 14 days you won't be billed. 
Subscribe to News24
Voting Booth
The ANC's leadership race is heating up. Who do you think will be elected party president at Nasrec in December?
Please select an option Oops! Something went wrong, please try again later.
Results
Nkosazana Dlamini-Zuma has got it in the bag
6% - 329 votes
I foresee a second term for Cyril Ramaphosa
82% - 4189 votes
Don’t discount a Zweli Mkhize win
12% - 603 votes
Vote
Rand - Dollar
18.09
-0.8%
Rand - Pound
20.21
-0.2%
Rand - Euro
17.74
-0.1%
Rand - Aus dollar
11.59
-0.3%
Rand - Yen
0.13
-0.1%
Gold
1,660.90
0.0%
Silver
19.03
0.0%
Palladium
2,166.50
0.0%
Platinum
864.50
0.0%
Brent Crude
85.14
-2.4%
Top 40
57,390
+0.8%
All Share
63,726
+0.7%
Resource 10
60,230
+0.7%
Industrial 25
77,400
+0.8%
Financial 15
13,796
+0.7%
All JSE data delayed by at least 15 minutes Iress logo
Editorial feedback and complaints

Contact the public editor with feedback for our journalists, complaints, queries or suggestions about articles on News24.

LEARN MORE